Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Corselli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Anti-Cancer Drugs|May 1, 1992
A pilot study comparing different dose levels and administration schedules of interferon-alpha 2b combined with epirubicin for prevention of recurrence in bladder cancerV Serretta, C Pavone, G Corselli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Intravesical mitoxantrone in superficial bladder tumours (Ta-T1)V Serretta, G Corselli, C Pavone, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|January 7, 1998
[The Urologic Cooperative Group of the EORTC. Structure, scope, research, results]M Pavone-Macaluso, G Corselli, G B Ingargiola, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicinM Pavone-Macaluso, M Tripi, G B Ingargiola, et al.
Urological Research|January 1, 1993
Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot studyV Serretta, G Corselli, B Piazza, et al.
European Urology|January 1, 1992
Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Significance of monoclonal and multiclonal varieties of DNA aneuploidyR Campanella, A Russo, S Plaja, et al.
European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Anti-Cancer Drugs|May 1, 1992
A pilot study comparing different dose levels and administration schedules of interferon-alpha 2b combined with epirubicin for prevention of recurrence in bladder cancerV Serretta, C Pavone, G Corselli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Intravesical mitoxantrone in superficial bladder tumours (Ta-T1)V Serretta, G Corselli, C Pavone, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|January 7, 1998
[The Urologic Cooperative Group of the EORTC. Structure, scope, research, results]M Pavone-Macaluso, G Corselli, G B Ingargiola, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1993
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicinM Pavone-Macaluso, M Tripi, G B Ingargiola, et al.
Urological Research|January 1, 1993
Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot studyV Serretta, G Corselli, B Piazza, et al.
European Urology|January 1, 1992
Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Significance of monoclonal and multiclonal varieties of DNA aneuploidyR Campanella, A Russo, S Plaja, et al.
European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.
Pageof 1